Article Details
Retrieved on: 2024-03-24 06:29:50
Tags for this article:
Click the tags to see associated articles and topics
Summary
Sam Altman, OpenAI's CEO, is venturing into biohacking with Retro Biosciences aiming to extend human lifespan by focusing on cellular reprogramming, along with other anti-aging techniques, aligning with his interest in transhumanism and rejuvenation.
Article found on: www.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here